The Redox Podcast 5: 2019 review and look ahead to 2020

2019 was another eventful year for both Redox and the healthcare industry. Redox Co-founders Luke Bonney, James Lloyd and Niko Skievaski discuss a wide range of topics – from the company’s remarkable progress in its first five years to notable market activity in the year past and predictions for 2020 and the new decade ahead.

Key Moments

1:26 – The first five years of Redox
8:40 – Tech giants becoming more active in healthcare
13:52 – The advantages of Redox being a remote workplace
19:18 – Helping organizations with digital transformation
22:38 – Predictions for 2020 and the decade ahead

Redox wishes everyone a healthy and prosperous 2020. Thank you for listening to the Redox podcast!

Related Posts

Podcasts

Challenges and opportunities in expanding access and equity in clinical trials with Tony Clapsis on Diagnosing Healthtech

https://www.youtube.com/watch?v=btqvFGC384s Clinical trials are notoriously inefficient. Almost 90% of trials fail to reach their recruitment goals and with dropout rates…

By Abbey Cox – April 8, 2024

Podcasts

Healthcare cybersecurity post-hack with Scott Giordano on Diagnosing Healthtech

https://www.youtube.com/watch?v=HMWADxNZDic&t=2s The implications of the recent healthcare hack continue to reverberate through the ecosystem. Many are wondering with…

By Abbey Cox – April 1, 2024

Podcasts

The systemic impact of ransomware on the revenue cycle and cash flows with Ben Reigle on Diagnosing Healthtech

https://www.youtube.com/watch?v=51vHolCtCBQ The recent ransomware attack on one of the largest U.S. clearinghouses for medical claims has exposed the…

By Abbey Cox – March 11, 2024